Different Potencies of Angiotensin Receptor Blockers at Suppressing Adrenal β-Arrestin1–Dependent Post-Myocardial Infarction Hyperaldosteronism
Authors:
- Anastasios LymperopoulosAnastasios Lymperopoulos
- Emmanuel SturchlerESEmmanuel Sturchler
- Ashley Bathgate-SirykABAshley Bathgate-Siryk
- Samalia DabulSDSamalia Dabul
- Dilayda GarciaDGDilayda Garcia
- Karlee WalklettKWKarlee Walklett
- Giuseppe RengoGiuseppe Rengo
- Patricia McDonaldPMPatricia McDonald
- Walter J. KochWKWalter J. Koch
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Adrenal Beta-Arrestin 1 Inhibition In Vivo Attenuates Post-Myocardial Infarction Progression to Heart Failure and Adverse Remodeling Via Reduction of Circulating Aldosterone LevelsJACC, 2011
- The Effect of Renin-Angiotensin System Inhibitors on Mortality and Heart Failure Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction: A Systematic Review and Meta-AnalysisJournal of Cardiac Failure, 2010
- An adrenal β-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivoProceedings of the National Academy of Sciences, 2009
- Irbesartan in Patients with Heart Failure and Preserved Ejection FractionNew England Journal of Medicine, 2008
- The incidence and implications of aldosterone breakthroughNature Clinical Practice Nephrology, 2007